tradingkey.logo

NewGenIvf Group Ltd

NIVF
View Detailed Chart
0.797USD
-0.020-2.49%
Close 12/24, 13:00ETQuotes delayed by 15 min
343.36KMarket Cap
0.00P/E TTM

NewGenIvf Group Ltd

0.797
-0.020-2.49%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.49%

5 Days

-11.39%

1 Month

-51.34%

6 Months

-97.05%

Year to Date

-99.96%

1 Year

-99.95%

View Detailed Chart

TradingKey Stock Score of NewGenIvf Group Ltd

Currency: USD Updated: 2025-12-24

Key Insights

NewGenIvf Group Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered undervalued, ranking 74/78 in the Healthcare Providers & Services industry.Institutional ownership is low.Over the past month, multiple analysts have rated it as , with the highest price target at 75.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

NewGenIvf Group Ltd's Score

Industry at a Glance

Industry Ranking
74 / 78
Overall Ranking
521 / 4562
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
75.000
Target Price
+5036.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

NewGenIvf Group Ltd Highlights

StrengthsRisks
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.43M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.79K shares, increasing 24.77% quarter-over-quarter.

NewGenIvf Group Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

NewGenIvf Group Ltd Info

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Ticker SymbolNIVF
CompanyNewGenIvf Group Ltd
CEOWing Fung (Siu)
Websitehttps://newgenivf.com/

FAQs

What is the current price of NewGenIvf Group Ltd (NIVF)?

The current price of NewGenIvf Group Ltd (NIVF) is 0.797.

What is the symbol of NewGenIvf Group Ltd?

The ticker symbol of NewGenIvf Group Ltd is NIVF.

What is the 52-week high of NewGenIvf Group Ltd?

The 52-week high of NewGenIvf Group Ltd is 2450.000.

What is the 52-week low of NewGenIvf Group Ltd?

The 52-week low of NewGenIvf Group Ltd is 0.781.

What is the market capitalization of NewGenIvf Group Ltd?

The market capitalization of NewGenIvf Group Ltd is 343.36K.

What is the net income of NewGenIvf Group Ltd?

The net income of NewGenIvf Group Ltd is -524.64K.

Is NewGenIvf Group Ltd (NIVF) currently rated as Buy, Hold, or Sell?

According to analysts, NewGenIvf Group Ltd (NIVF) has an overall rating of --, with a price target of 75.000.

What is the Earnings Per Share (EPS TTM) of NewGenIvf Group Ltd (NIVF)?

The Earnings Per Share (EPS TTM) of NewGenIvf Group Ltd (NIVF) is 576.582.
KeyAI